To Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Participants With Symptoms of Common Cold
Status:
Completed
Trial end date:
2017-06-07
Target enrollment:
Participant gender:
Summary
This study will be conducted in adult participants with symptoms of common cold assessing if
1146A nasal spray reduces the severity of symptoms of the common cold compared to placebo.
The study will also evaluate the safety of 1146A compared to placebo.